Table 1.
Association between miR-124 expression and clinicopathological variables of the glioma patients
| Variables | Number of cases | miR-124 mRNA level | p-value | ||
|---|---|---|---|---|---|
|
|
|||||
| Low, n (%) | Medium, n (%) | High, n (%) | |||
| Overall | 84 | 21 (25) | 40 (47.6) | 23 (27.4) | |
| Age (Years) | <0.001 | ||||
| ≤50 | 43 | 23 (53.5) | 14 (32.6) | 6 (13.9) | |
| >50 | 41 | 18 (27.9) | 22 (53.6) | 1 (2.5) | |
| Gender | 0.784 | ||||
| Male | 45 | 14 (31.1) | 23 (51.1) | 8 (17.8) | |
| Female | 43 | 12 (27.9) | 18 (41.8) | 13 (30.3) | |
| Pathological grade (WHO) | <0.001 | ||||
| Grade I | 12 | 0 (0) | 8 (66.7) | 4 (33.3) | |
| Grade II | 13 | 6 (46.1) | 5 (38.5) | 2 (15.4) | |
| Grade III | 24 | 11 (45.8) | 10 (41.7) | 3 (12.5) | |
| Grade IV | 35 | 19 (54.3) | 14 (40.0) | 2 (5.7) | |